ArticleMedicine international
Atypical hemolytic uremic syndrome associated with pregnancy: A case report.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemolytic uremic syndrome (HUS) is a microangiopathy characterized by hemolytic anemia, thrombocytopenia and acute renal failure. It affects 2 to 3 individuals per 100,000 in the population, with a higher prevalence among adult women. HUS is caused by the abnormal activation of the complement system, leading to endot2helial damage and the formation of microthrombi in renal capillaries, which determines the severity of the condition. Pregnancy may predispose individuals to HUS due to changes in the maternal immune system. The present study describes the case of a 29-year-old female patient who presented postpartum with purulent discharge, severe anemia (hemoglobin level, 4.6 g/dl), thrombocytopenia, acute kidney injury (creatinine level, 10.6 mg/dl) and elevated levels of lactate dehydrogenase (1,450 U/l). Despite antibiotic therapy and blood transfusions, she developed anuria, metabolic acidosis and acute pulmonary edema, requiring admission to the intensive care unit and mechanical ventilation. A peripheral blood smear revealed >10 schistocytes per high-power field. A kidney biopsy confirmed HUS. Following stabilization with plasma infusions, corticosteroids and supportive care, she was discharged with intermittent hemodialysis and continues under nephrology follow-up. On the whole, HUS is a rare condition that is increasingly recognized. The case presented herein highlights the rapid clinical progression of this condition, emphasizing the importance of diagnostic suspicion to reduce mortality and improve prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.